Literature DB >> 12717830

Nimesulide inhibits proliferation via induction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line.

Jian-Ying Li1, Xiao-Zhong Wang, Feng-Lin Chen, Jie-Ping Yu, He-Sheng Luo.   

Abstract

AIM: To evaluate the potential role of Nimesulide, a selective COX-2 inhibitor, in proliferation and apoptosis of gastric adenocarcinoma cells SGC7901.
METHODS: Cell counts and MTT assay were used to quantify the influence of Nimesulide in the proliferation of SGC7901 cells. Transmission electron microscopy and flow cytometry were used to observe the induction of Nimesulide the apoptosis of SGC7901 cells and influence in the distribution of cell cycle. The expression of P27(kip1) protein was observed by immunocytochemical staining.
RESULTS: SGC-7901 Cells treated with Nimesulide at various concentrations exhibited a profound dose- and time-dependent reduction in the proliferation rate over the 72 h test period. The highest survival rate of the cells was 78.7 %, but the lowest being 22.7 %. Nimesulide induced apoptosis of the cells in a dose-dependent and non-linear manner and increased the proportion of cells in the G(0)/G(1) phase and decreased the proportion in the S and G(2)/M phase of the cell cycle. Meanwhile, Nimesulide could up-regulate the expression of P27(kip1) protein.
CONCLUSION: The induction of apoptosis and cell cycle arrest are both anti-proliferative responses that likely contribute to the antineoplastic action of nimesulide on SGC-7901 cells. The up-regulation of P27(kip1) gene may contribute to the accumulation of these cells in the G(0)/G(1) phase following treatment with Nimesulide. Selective COX-2 inhibitor may be a new channel of the chemoprevention and chemotherapy for gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717830      PMCID: PMC4611397          DOI: 10.3748/wjg.v9.i5.915

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

1.  Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells.

Authors:  Z Zhang; R N DuBois
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

2.  Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

Authors:  T Kawamori; C V Rao; K Seibert; B S Reddy
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

3.  Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.

Authors:  M A Molina; M Sitja-Arnau; M G Lemoine; M L Frazier; F A Sinicrope
Journal:  Cancer Res       Date:  1999-09-01       Impact factor: 12.701

4.  Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.

Authors:  Ximing Tang; Yun Jie Sun; Elizabeth Half; M Tien Kuo; Frank Sinicrope
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

5.  Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.

Authors:  T Hida; J Leyton; A N Makheja; P Ben-Av; T Hla; A Martinez; J Mulshine; S Malkani; P Chung; T W Moody
Journal:  Anticancer Res       Date:  1998 Mar-Apr       Impact factor: 2.480

6.  Progastrin and cyclooxygenase-2 in colorectal cancer.

Authors:  Peter C Konturek; Władysław Bielanski; Stanislaw J Konturek; Artur Hartwich; Piotr Pierzchalski; Macien Gonciarz; Krzysztof Marlicz; Teresa Starzynska; Monika Zuchowicz; Zbigniew Darasz; Jens P Götze; Jens F Rehfeld; Eckhart G Hahn
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

7.  NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.

Authors:  X H Liu; S Yao; A Kirschenbaum; A C Levine
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

8.  Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.

Authors:  G A Piazza; A L Rahm; M Krutzsch; G Sperl; N S Paranka; P H Gross; K Brendel; R W Burt; D S Alberts; R Pamukcu
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

9.  Evidence for separate mechanisms of antiproliferative action of indomethacin and prostaglandin on MCF-7 breast cancer cells.

Authors:  P Planchon; N Veber; V Magnien; G Prévost; A B Starzec; L Israël
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  Aspirin and the risk of colorectal cancer in women.

Authors:  E Giovannucci; K M Egan; D J Hunter; M J Stampfer; G A Colditz; W C Willett; F E Speizer
Journal:  N Engl J Med       Date:  1995-09-07       Impact factor: 91.245

View more
  14 in total

1.  From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.

Authors:  Bo Zhong; Xiaohan Cai; Snigdha Chennamaneni; Xin Yi; Lili Liu; John J Pink; Afshin Dowlati; Yan Xu; Aimin Zhou; Bin Su
Journal:  Eur J Med Chem       Date:  2011-11-15       Impact factor: 6.514

2.  COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer.

Authors:  Johanna Mrena; Jan-Patrik Wiksten; Arto Kokkola; Stig Nordling; Ari Ristimäki; Caj Haglund
Journal:  Tumour Biol       Date:  2009-12-18

3.  The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cells.

Authors:  Cornelia Czembirek; Christina Eder-Czembirek; Boban M Erovic; Dritan Turhani; Andreas Spittler; Edgar Selzer; Richard Pötter; Dietmar Thurnher
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

4.  Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-03-20       Impact factor: 7.012

5.  The effects of nimesulide combined with cisplatin on lung cancer.

Authors:  Lihua Xing; Zhenxiang Zhang; Yongjian Xu; Huilan Zhang; Jianbo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

6.  Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.

Authors:  Suo-Lin Fu; Yun-Lin Wu; Yong-Ping Zhang; Min-Min Qiao; Ying Chen
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

7.  Nimesulide inhibits crypt epithelial cell proliferation at 6 hours in the small intestine in CD-1 mice.

Authors:  M Alice McGarvey; Fardod O'Kelly; Rajunor R Ettarh
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

8.  Protective role of metallothionein (I/II) against pathological damage and apoptosis induced by dimethylarsinic acid.

Authors:  Guang Jia; Yi-Qun Gu; Kung-Tung Chen; You-Yong Lu; Lei Yan; Jian-Ling Wang; Ya-Ping Su; J C Gaston Wu
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

9.  Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.

Authors:  Wei Li; Jie Wang; Hong-Ru Jiang; Xiao-Li Xu; Jun Zhang; Mei-Lin Liu; Ling-Yun Zhai
Journal:  Int J Mol Sci       Date:  2011-01-18       Impact factor: 5.923

10.  Nimesulide alters cell recruitment into mitosis in murine intestinal crypts without influencing the cell production rate.

Authors:  M Alice McGarvey; Gary Bass; R R Ettarh
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.